Pro-Substance P for Evaluation of Risk in Acute Myocardial Infarction-Reference-Cited by-同舟云学术

Pro-Substance P for Evaluation of Risk in Acute Myocardial Infarction

Published:2014-10 Issue:16 Volume:64 Page:1698-1707
ISSN:0735-1097
Container-title:Journal of the American College of Cardiology
language:en
Short-container-title:Journal of the American College of Cardiology

Author:

Ng Leong L.,Sandhu Jatinderpal K.,Narayan Hafid,Quinn Paulene A.,Squire Iain B.,Davies Joan E.,Struck Joachim,Bergmann Andreas,Maisel Alan,Jones Donald J.L.

Publisher

Elsevier BV

Subject

Cardiology and Cardiovascular Medicine

Reference27 articles.

1. Neurotransmitter functions of mammalian tachykinins;Otsuka;Physiol Rev,1993

2. Actions of tachykinins within the heart and their relevance to cardiovascular disease;Hoover;Jpn J Pharmacol,2000

3. Impaired muscarinic endothelium-dependent relaxation and cyclic guanosine 5′-monophosphate formation in atherosclerotic human coronary artery and rabbit aorta;Bossaller;J Clin Invest,1987

4. Implication of substance P in myocardial contractile function during ischemia in rats;Wang;Regul Pept,2011

5. The role of substance P in myocardial dysfunction during ischemia and reperfusion;Chiao;Naunyn Schmiedebergs Arch Pharmacol,1996

Cited by 17 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Association of hypertension burden with stroke risk in patients with heart failure with preserved ejection fraction;Heliyon;2024-03

2. Cathepsin S Levels and Survival Among Patients With Non-ST-Segment Elevation Acute Coronary Syndromes;Journal of the American College of Cardiology;2022-09

3. Combined Assessment of D-Dimer with the Get with the Guidelines—Heart Failure Risk Score and N-Terminal Pro-B-Type Natriuretic Peptide in Patients with Acute Decompensated Heart Failure with Preserved and Reduced Ejection Fraction;Journal of Clinical Medicine;2021-08-13

4. Neprilysin inhibition does not alter dynamic of proenkephalin‐A 119‐159 and pro‐substance P in heart failure;ESC Heart Failure;2021-03-20

5. Detection of early breast cancer beyond mammographic screening: a promising biomarker panel;Biomarkers in Medicine;2019-09